Facility was expanded to accommodate new GMP manufacturing suites and onsite packaging line for larger scale production and cost reduction.
Elite chairman and CEO Jerry Treppel said, "Shipping packaged product and manufacturing larger batch sizes from our new manufacturing space was one of our publicly announced operational goals for fiscal year 2013."
US-based Elite Pharmaceuticals develops oral sustained and controlled release products.